Logo

Illumina Certifies Integragen for GoldenGate, Infinium Genotyping

Jun 18, 2007
NEW YORK (GenomeWeb News) - Integragen has received certification as a service provider for Illumina's GoldenGate and Infinium genotyping technologies, Illumina said today.
 
Illumina said the GoldenGate assay is designed for DNA methylation profiling, and offers a combination of high sample throughput, high multiplexing, and single-site CpG resolution. The Infinium BeadArray is used for custom SNP assays, and offers multi-sample BeadChip formats and high-density architecture, the company said.
 
Integragen, based in Evry, France, has already supplied the Illumina technology to study the loss of heterozygosity in liver tumors at the Human Polymorphism Study Center in Paris, Illumina said.
 
Illumina said that its certification process includes minimum data generation, data certification, and an on-site audit of the labs and processes.

Breaking News
The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.